micro-community-banner
  • Saved

8mo
ADA 2025 Highlights: Obesity Therapies, Islet Cell Advances, and Oral GLP-1 Outcomes in T2D

At ADA 2025, Dr. Mark Atkinson (University of Florida Diabetes Institute) highlighted the systemic benefits of obesity-targeted therapies, including cardiometabolic and cognitive improvements, while noting concerns about implementation and potential muscle loss. Emerging advances in stem cell–derived islet transplantation for type 1 diabetes show promise in reducing insulin dependence. Dr. John Buse (University of North Carolina) presented SOUL trial data indicating that oral GLP-1 receptor agonist therapy reduced major adverse cardiovascular events—CV death, nonfatal MI, or stroke—by 14%, with additional reductions in limb complications in high-risk patients with type 2 diabetes.

  • Saved

9mo
Transcatheter Tricuspid Valve Replacement - PubMed

Transcatheter Tricuspid Valve Replacement - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39580719/

Transcatheter tricuspid valve replacement (TTVR) has emerged as a promising intervention for the treatment of severe tricuspid regurgitation with complex valve morphology. This consensus document provides a comprehensive overview of...

 

This consensus review outlines current practices, benefits, and challenges of transcatheter tricuspid valve replacement, offering expert guidance on patient selection, procedures, complications, and long-term management following device approval.

  • Saved

9mo
infographic infographic 
  • Saved

9mo
Robotic-assisted coronary artery bypass grafting: how I teach it - PubMed

Robotic-assisted coronary artery bypass grafting: how I teach it - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39157180/

The first robotic cardiac operation was performed more than two decades ago. This paper describes the distinct steps and components necessary for teaching robotic-assisted minimally invasive direct coronary artery bypass...

 

Robotic-assisted MIDCAB requires structured training, team coordination, and institutional support. It offers clinical and economic benefits over sternotomy CABG, with improved outcomes, shorter recovery, and reduced hospital resource utilization.

  • Saved

9mo
Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial - PubMed

Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39215972/

ClinicalTrials.gov Identifier: NCT04053816.

 

In post-CABG patients, relaxing potassium supplementation thresholds to <3.6 mEq/L was noninferior to tighter control, with no increase in atrial fibrillation and significantly reduced costs and intervention frequency.